Your browser doesn't support javascript.
loading
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.
Ameratunga, Malaka; Asadi, Khashayar; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel; Knight, Simon; Mitchell, Paul; Boutros, Paul; John, Thomas.
Afiliação
  • Ameratunga M; Department of Medical Oncology, Austin Health, Olivia-Newton John Cancer and Wellness Centre, Victoria, Australia.
  • Asadi K; Department of Pathology, Austin Health, Victoria, Australia.
  • Lin X; Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada.
  • Walkiewicz M; The Olivia Newton-John Cancer Research Institute, Victoria, Australia.
  • Murone C; Department of Pathology, Austin Health, Victoria, Australia.
  • Knight S; The Olivia Newton-John Cancer Research Institute, Victoria, Australia.
  • Mitchell P; Department of Thoracics, Austin Health, Victoria, Australia.
  • Boutros P; Department of Medical Oncology, Austin Health, Olivia-Newton John Cancer and Wellness Centre, Victoria, Australia.
  • John T; Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada.
PLoS One ; 11(4): e0153954, 2016.
Article em En | MEDLINE | ID: mdl-27104612

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article